Literature DB >> 10442471

Spatial analysis of Percutaneous Transluminal Coronary Angioplasty (PTCA) in Austria.

R Strauss1, C Pfeifer, H Ulmer, V Mühlberger, K P Pfeiffer.   

Abstract

STUDY
OBJECTIVES: To investigate the geographical distribution of Percutaneous Transluminal Coronary Angioplasty (PTCA) and morbidity for coronary heart disease, angina pectoris and myocardial infarction by spatial analysis of the standardized morbidity rates (SMR) on district level. To identify clusters by Moran's I Statistic and the Regional Spatial Autocorrelation Coefficient (RSAC) of Munasinghe and Morris. To investigate demand factor morbidity and supply factor health care infrastructure on the district level as reasons for geographical disparity. To describe characteristics of the cluster population and intervention centres. STUDY
DESIGN: Retrospective record linkage study.
SETTING: All hospitals and cardiological centres in Austria (n = 150) which performed the Minimum Basic Data Set (MBDS). PATIENTS: All Austrian residents who were diagnosed for myocardial infarction, coronary heart disease or angina pectoris in 1995 (n = 87,174).
MEASUREMENTS AND MAIN RESULTS: One 'positive' PTCA cluster (all SMRs > or =0.96) and one 'negative' PTCA cluster (all SMRs < or =0.59) were identified. They differed significantly in morbidity rate, intervention rate and available cardiological beds. The tendency to inverse relation between PTCA utilization and morbidity in the 'negative' cluster supported the thesis of 'inverse care law'. Austrianwide no significant correlation was found between the SMR of PTCA-application and both demand factor and supply factors. Nevertheless, differences between the clusters concerning number and capacity of intervention centres and density of specialists pointed to supply factors as reasons for geographical disparity. The ongoing trend of steady expansion of existing intervention centres and establishment of new ones will reduce the extent of geographical variation in future.

Entities:  

Mesh:

Year:  1999        PMID: 10442471     DOI: 10.1023/a:1007577516433

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  19 in total

1.  Comparison of costs of percutaneous transluminal coronary angioplasty and coronary bypass surgery for patients with angina pectoris.

Authors:  M van den Brand; C van Halem; F van den Brink; P de Feyter; P Serruys; H Suryapranata; K Meeter; E Bos; F J van Dalen
Journal:  Eur Heart J       Date:  1990-08       Impact factor: 29.983

2.  Coronary angioplasty in the United Kingdom. Report of a Working Party of the British Cardiac Society.

Authors: 
Journal:  Br Heart J       Date:  1991-10

3.  Determinants of the use of coronary angiography and revascularization after thrombolysis for acute myocardial infarction.

Authors:  L Pilote; D P Miller; R M Califf; J S Rao; W D Weaver; E J Topol
Journal:  N Engl J Med       Date:  1996-10-17       Impact factor: 91.245

4.  The inverse care law.

Authors:  J T Hart
Journal:  Lancet       Date:  1971-02-27       Impact factor: 79.321

5.  Effects of morbidity, age, gender and region on percutaneous transluminal coronary angioplasty (PTCA) utilisation.

Authors:  R Strauss; C Pfeifer; V Muhlberger; H Ulmer; K P Pfeiffer
Journal:  Public Health       Date:  1999-03       Impact factor: 2.427

6.  Coronary revascularisation: why do rates vary geographically in the UK?

Authors:  N Black; S Langham; M Petticrew
Journal:  J Epidemiol Community Health       Date:  1995-08       Impact factor: 3.710

7.  Regional variations in the use of common surgical procedures: within and between England and Wales, Canada and the United States of America.

Authors:  K McPherson; P M Strong; A Epstein; L Jones
Journal:  Soc Sci Med A       Date:  1981-05

8.  Localization of disease clusters using regional measures of spatial autocorrelation.

Authors:  R L Munasinghe; R D Morris
Journal:  Stat Med       Date:  1996 Apr 15-May 15       Impact factor: 2.373

9.  Differences in the treatment of myocardial infarction between the United States and Canada. A survey of physicians in the GUSTO trial.

Authors:  L Pilote; C Granger; P W Armstrong; D B Mark; M A Hlatky
Journal:  Med Care       Date:  1995-06       Impact factor: 2.983

10.  Diagnosis and treatment of coronary disease: comparison of doctors' attitudes in the USA and the UK.

Authors:  R H Brook; J B Kosecoff; R E Park; M R Chassin; C M Winslow; J R Hampton
Journal:  Lancet       Date:  1988-04-02       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.